Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
about
Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons"Advances in Lipidomics for Cancer Biomarkers DiscoveryFASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and GBiofluid lipidome: a source for potential diagnostic biomarkers.Racial disparity in metabolic regulation of cancer.Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.Lipidomic approach for stratification of acute myeloid leukemia patients.Gene-set Analysis with CGI Information for Differential DNA Methylation ProfilingUrinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell CarcinomaLipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung CancerPlasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile.Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics.Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema.Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.Analysis of glycero-lysophospholipids in gastric cancerous ascites.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers.Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer
P2860
Q26747281-61CA1CDA-EC8A-464A-9B13-5072F1937F1FQ28079507-69AA1814-C09C-4739-B172-7F6F4CD6A0DEQ33809433-8EEDF7FA-99E6-4E4A-8847-48AAA2C7CE02Q33822645-D6B1990F-417A-47BC-BE9A-542D5B05D1CAQ33906704-BAEB1513-56C7-4565-8A41-F519C034BB8DQ36045221-C2BF0D0A-CDD7-4A4A-9BBC-671A1E97CCDBQ36282427-1EF76EC5-C78F-473A-8E98-E02F63E085FDQ36811822-237A29D4-151A-4C72-9C6A-FDA4DBBAAF47Q36963678-CBC79805-36ED-49DD-A4CF-CBB0D42DB5E5Q37022229-9972E4BD-DDEB-4E15-B65F-BFA1D43681A0Q37054261-B2303461-A5CC-4BA3-AEB3-E5E444F251FEQ37339704-476252E0-40C1-43F6-984A-C9497AB8225DQ37387806-2B71787B-59A7-475B-B4F6-895FFBEFAF0BQ38762944-2EF97926-F10E-4BEE-9331-0F70953F614CQ38822368-3F482EB1-C136-486F-8EAE-1F2714291A5BQ38864602-9DF65843-5110-4788-BEC1-52704FC88C7DQ41317042-907E1D63-4360-4B4B-B267-610D831B0072Q41459821-8AEDFC9A-12A8-4E5E-BE66-D897FC26186BQ42278873-7A1F1386-B6EC-4459-8CCA-9ED7C7F5D5A3Q46246621-2BAF0352-C3D7-41EE-82DA-A7E1876E40C6Q50052924-FB1FBE1C-6CB4-43D3-8EDE-CA14AB72872AQ58797016-BAF82268-1E70-4238-8557-A1C9FD8CC418
P2860
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@ast
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@en
type
label
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@ast
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@en
prefLabel
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@ast
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@en
P2093
P2860
P50
P356
P1476
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.
@en
P2093
Eyra Marien
Hendrik Dienemann
Jens Wouters
Jonas Dehairs
Michael Meister
Michael Thomas
Muralidhararao Bagadi
Philipp A Schnabel
Raf Van de Plas
Richard M Caprioli
P2860
P304
P356
10.1002/IJC.29517
P577
2015-04-07T00:00:00Z